Research Field: Neuroscience, Mental Health
Schizophrenia is a devastating psychiatric illness that debilitates people for life. Current treatments for schizophrenia are largely ineffective and have severe side effects and thus better treatment options are urgently needed.
A/Prof. Hill is using cutting edge neuroscience technologies to understand what is happening in the brains of people with schizophrenia. She has identified key brain cells and molecules that are altered in schizophrenia and is developing new targeted therapies to recover brain changes.
A/Prof Hill is a neuroscience ambassador for the ‘HOPE’ campaign of the Victorian non-for-profit, One in Five, bringing hope to people with a mental illness through research. She has given multiple public lectures on biological research in the mental health space. She has led school outreach programs and has been a leading voice in the community through multiple media campaigns including mainstream media (ABC television and radio), and pedestrian TV (both Fairfax and Newscorp mastheads).
Rachel completed her PhD in 2007 at Monash University and is currently head of the Behavioural Neuroscience program in the Department of Psychiatry at Monash University.